{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:21:04Z","timestamp":1784168464738,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03048","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T08:31:16Z","timestamp":1546590676000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Source of Circulating Pentraxin 3 in Septic Shock Patients"],"prefix":"10.3389","volume":"9","author":[{"given":"Chlo\u00e9","family":"Albert Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Mommert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Boccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Pachot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Leray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Delwarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brengel-Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Trouillet-Assant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3238\/arztebl.2016.0159","article-title":"Hospital incidence and mortality rates of sepsis","volume":"113","author":"Fleischmann","year":"2016","journal-title":"Deutsch Arzteblatt int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a humoral pattern recognition molecule, in innate immunity, tissue repair, and cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.smim.2016.10.012","article-title":"Innate immunity, hemostasis and matrix remodeling: PTX3 as a link","volume":"28","author":"Doni","year":"2016","journal-title":"Semin Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yexmp.2014.11.009","article-title":"Differential expression of pentraxin 3 in neutrophils","volume":"98","author":"Razvina","year":"2015","journal-title":"Exp mol pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20061301","article-title":"The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps","volume":"204","author":"Jaillon","year":"2007","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"970","DOI":"10.4049\/jimmunol.1100261","article-title":"Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction","volume":"187","author":"Maugeri","year":"2011","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fimmu.2012.00378","article-title":"Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps","volume":"3","author":"Daigo","year":"2012","journal-title":"Front immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/eci.12704","article-title":"Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial","volume":"47","author":"Caironi","year":"2017","journal-title":"Eur j clin invest."},{"key":"B12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00134-010-1752-5","article-title":"Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality","volume":"36","author":"Mauri","year":"2010","journal-title":"Intens Care Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression","volume":"14","author":"Venet","year":"2018","journal-title":"Nat rev Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1189\/jlb.4A0415-168RR","article-title":"Marked alterations of neutrophil functions during sepsis-induced immunosuppression","volume":"98","author":"Demaret","year":"2015","journal-title":"J Leukoc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e68218","DOI":"10.1371\/journal.pone.0068218","article-title":"Identification of biomarkers of response to IFNg during endotoxin tolerance: application to septic shock","volume":"8","author":"Allantaz-Frager","year":"2013","journal-title":"PLoS ONE"},{"key":"B17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12864-018-4901-9","article-title":"LTR-retrotransposon transcriptome modulation in response to endotoxin-induced stress in PBMCs","volume":"19","author":"Mommert","year":"2018","journal-title":"BMC genom."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7184","DOI":"10.4049\/jimmunol.177.10.7184","article-title":"Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells","volume":"177","author":"Aneja","year":"2006","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13054-017-1625-1","article-title":"Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome","volume":"21","author":"Antonakos","year":"2017","journal-title":"Crit Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1016\/j.celrep.2016.08.011","article-title":"Standardized whole-blood transcriptional profiling enables the deconvolution of complex induced immune responses","volume":"16","author":"Urrutia","year":"2016","journal-title":"Cell Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00134-006-0204-8","article-title":"Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock","volume":"32","author":"Monneret","year":"2006","journal-title":"Intens Care Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1373\/clinchem.2005.052639","article-title":"Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study","volume":"51","author":"Docke","year":"2005","journal-title":"Clin chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/cc10452","article-title":"A dynamic view of mHLA-DR expression in management of severe septic patients","volume":"15","author":"Monneret","year":"2011","journal-title":"Crit Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"5125","DOI":"10.18632\/oncotarget.23701","article-title":"Pentraxin-3, procalcitonin and lactate as prognostic markers in patients with sepsis and septic shock","volume":"9","author":"Hu","year":"2018","journal-title":"Oncotarget"},{"key":"B25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1515\/CCLM.2009.110","article-title":"Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations","volume":"47","author":"Yamasaki","year":"2009","journal-title":"Clin chem lab med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/imr.12476","article-title":"Pentraxins in the activation and regulation of innate immunity","volume":"274","author":"Daigo","year":"2016","journal-title":"Immunol Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e17653","DOI":"10.1371\/journal.pone.0017653","article-title":"High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study","volume":"6","author":"Huttunen","year":"2011","journal-title":"PLoS ONE"},{"key":"B28","unstructured":"RubinoM Epigenetic Modifications Abolish the Expression of the Long Pentraxin PTX3 in Human Tumors.2015"},{"key":"B29","doi-asserted-by":"publisher","first-page":"R252","DOI":"10.1186\/cc10513","article-title":"mRNA-based approach to monitor recombinant gamma-interferon restoration of LPS-induced endotoxin tolerance","volume":"15","author":"Turrel-Davin","year":"2011","journal-title":"Crit Care"},{"key":"B30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cyto.2016.07.012","article-title":"Pentraxin 3 is an anti-inflammatory protein associated with lipid-induced interleukin 10 in vitro","volume":"86","author":"Slusher","year":"2016","journal-title":"Cytokine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ni.1854","article-title":"Regulation of leukocyte recruitment by the long pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cell.2015.01.004","article-title":"PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer","volume":"160","author":"Bonavita","year":"2015","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13223-015-0104-y","article-title":"TNF up-regulates pentraxin3 expression in human airway smooth muscle cells via JNK and ERK1\/2 MAPK pathways","volume":"11","author":"Zhang","year":"2015","journal-title":"Allergy asthma clin immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.4049\/jimmunol.175.12.8303","article-title":"TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK","volume":"175","author":"Han","year":"2005","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1097\/CCM.0000000000002294","article-title":"Sepsis patients display a reduced capacity to activate nuclear factor-kappaB in multiple cell types","volume":"45","author":"Hoogendijk","year":"2017","journal-title":"Crit Care Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"12185","DOI":"10.1074\/jbc.275.16.12185","article-title":"mRNA and protein stability regulate the differential expression of pro- and anti-inflammatory genes in endotoxin-tolerant THP-1 cells","volume":"275","author":"Learn","year":"2000","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0890-8","article-title":"Review: the role and mechanisms of macrophage autophagy in sepsis","author":"Qiu","year":"2018","journal-title":"Inflammation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1126\/scisignal.aah4674","article-title":"Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers","volume":"10","author":"Thomas","year":"2017","journal-title":"Sci signal."},{"key":"B39","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/ATVBAHA.107.160606","article-title":"Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells","volume":"28","author":"Norata","year":"2008","journal-title":"Arterioscler thromb vasc biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"20234","DOI":"10.1074\/jbc.M100316200","article-title":"The phosphatidylinositol 3-kinase pathway selectively controls sil-1ra not interleukin-1beta production in the septic leukocytes","volume":"276","author":"Learn","year":"2001","journal-title":"J Biol Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1582-4934.2007.00061.x","article-title":"Role of the soluble pattern recognition receptor PTX3 in vascular biology","volume":"11","author":"Presta","year":"2007","journal-title":"J cell mol med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"ra88","DOI":"10.1126\/scisignal.2005522","article-title":"Protective effect of the long pentraxin PTX3 against histone-mediated endothelial cell cytotoxicity in sepsis","volume":"7","author":"Daigo","year":"2014","journal-title":"Sci signal."},{"key":"B43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/cvr\/cvw209","article-title":"Endothelial cell-derived pentraxin 3 limits the vasoreparative therapeutic potential of circulating angiogenic cells","volume":"112","author":"O'Neill","year":"2016","journal-title":"Cardiovasc res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03048\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T13:59:48Z","timestamp":1573653588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03048\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":43,"alternative-id":["10.3389\/fimmu.2018.03048"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03048","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"article-number":"3048"}}